E
Eris Lifesciences
Domestic pharmaceutical company focused on a wide range of products in the chronic and acute therapy segments
At a glance
- Status
- Listed
- Founded
- 2007
- Headquarters
- Ahmedabad, India
- Listing
- IPO 2017
- Sector
- Biotech & Life Sciences
- Outcome tier
- Thoroughbred$100M+ revenue
Knowledge graph
News
More headlines
Open roles
Eris Lifesciences in the Ahmedabad ecosystem
The Eris Lifesciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
- CCChrys Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Investments and acquisitions
Disclosed deals where Eris Lifesciences was the backer or acquirer, 2017–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Eris Lifesciences's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Eris Lifesciences's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Eris Lifesciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Eris Lifesciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

